These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11131147)

  • 1. Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D.
    Pimenta DC; Chen VC; Chao J; Juliano MA; Juliano L
    J Protein Chem; 2000 Jul; 19(5):411-8. PubMed ID: 11131147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin.
    Pimenta DC; Oliveira A; Juliano MA; Juliano L
    Biochim Biophys Acta; 2001 Jan; 1544(1-2):113-22. PubMed ID: 11341921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein.
    Chen VC; Chao L; Chao J
    J Biol Chem; 2000 Dec; 275(51):40371-7. PubMed ID: 10991942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New, sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops.
    Réhault S; Brillard-Bourdet M; Juliano MA; Juliano L; Gauthier F; Moreau T
    J Biol Chem; 1999 May; 274(20):13810-7. PubMed ID: 10318785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence.
    Zhou GX; Chao L; Chao J
    J Biol Chem; 1992 Dec; 267(36):25873-80. PubMed ID: 1334488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides.
    Melo RL; Alves LC; Del Nery E; Juliano L; Juliano MA
    Anal Biochem; 2001 Jun; 293(1):71-7. PubMed ID: 11373081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
    Gomes RA; Juliano L; Chagas JR; Hial V
    Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
    Pimenta DC; Fogaça SE; Melo RL; Juliano L; Juliano MA
    Biochem J; 2003 May; 371(Pt 3):1021-5. PubMed ID: 12578561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein.
    Chen VC; Chao L; Chao J
    J Biol Chem; 2000 Dec; 275(49):38457-66. PubMed ID: 10993887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.
    Pimenta DC; Chao J; Chao L; Juliano MA; Juliano L
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):473-9. PubMed ID: 10191281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
    Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a major heparin-binding site in kallistatin.
    Chen VC; Chao L; Pimenta DC; Bledsoe G; Juliano L; Chao J
    J Biol Chem; 2001 Jan; 276(2):1276-84. PubMed ID: 11016932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli.
    Chai KX; Chen LM; Chao J; Chao L
    J Biol Chem; 1993 Nov; 268(32):24498-505. PubMed ID: 8227002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity studies on Kallikrein-related peptidase 7 (KLK7) and effects of osmolytes and glycosaminoglycans on its peptidase activity.
    Oliveira JR; Bertolin TC; Andrade D; Oliveira LC; Kondo MY; Santos JA; Blaber M; Juliano L; Severino B; Caliendo G; Santagada V; Juliano MA
    Biochim Biophys Acta; 2015 Jan; 1854(1):73-83. PubMed ID: 25448018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Kallikrein-Related Peptidases 7 and 5 by Grafting Serpin Reactive-Center Loop Sequences onto Sunflower Trypsin Inhibitor-1 (SFTI-1).
    Jendrny C; Beck-Sickinger AG
    Chembiochem; 2016 Apr; 17(8):719-26. PubMed ID: 26574674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
    Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
    Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D.
    Yasuda Y; Kageyama T; Akamine A; Shibata M; Kominami E; Uchiyama Y; Yamamoto K
    J Biochem; 1999 Jun; 125(6):1137-43. PubMed ID: 10348917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural elements of kallistatin required for inhibition of angiogenesis.
    Miao RQ; Chen V; Chao L; Chao J
    Am J Physiol Cell Physiol; 2003 Jun; 284(6):C1604-13. PubMed ID: 12734113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects.
    Angelo PF; Lima AR; Alves FM; Blaber SI; Scarisbrick IA; Blaber M; Juliano L; Juliano MA
    J Biol Chem; 2006 Feb; 281(6):3116-26. PubMed ID: 16321973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.